BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3973072)

  • 1. Acute psychosis following phenelzine discontinuation.
    Liskin B; Roose SP; Walsh BT; Jackson WK
    J Clin Psychopharmacol; 1985 Feb; 5(1):46-7. PubMed ID: 3973072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam.
    Naylor MW; Grunhaus L; Cameron O
    J Nerv Ment Dis; 1987 Feb; 175(2):111-4. PubMed ID: 3806075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to abrupt discontinuation of phenelzine.
    Palladino A
    J Clin Psychopharmacol; 1983 Jun; 3(3):206-7. PubMed ID: 6875031
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
    Modai I; Beigel Y; Cygielman G
    J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open trial of MAO inhibitors in bulimia.
    Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
    J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosis following phenelzine discontinuation.
    J Clin Psychopharmacol; 1985 Dec; 5(6):360-1. PubMed ID: 4067006
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
    Rabkin JG; Quitkin FM; McGrath P; Harrison W; Tricamo E
    J Clin Psychopharmacol; 1985 Feb; 5(1):2-9. PubMed ID: 3973068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common side effects associated with monoamine oxidase inhibitors.
    Remick RA; Froese C; Keller FD
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):497-504. PubMed ID: 2748873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bulimia and monoamine oxidase inhibitors: a predictor study.
    Hardy BW; Waller DA; Orsulak PJ
    Tex Med; 1985 Oct; 81(10):39-42. PubMed ID: 3904070
    [No Abstract]   [Full Text] [Related]  

  • 10. Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
    McGrath PJ; Stewart JW; Tricamo E; Nunes EN; Quitkin FM
    J Clin Psychopharmacol; 1993 Jun; 13(3):224-5. PubMed ID: 8354742
    [No Abstract]   [Full Text] [Related]  

  • 11. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenelzine and psychosis.
    Jacobs LS; Green RA; Gillin JC; Wyatt RJ
    Hawaii Med J; 1976 Apr; 35(4):109-11. PubMed ID: 185165
    [No Abstract]   [Full Text] [Related]  

  • 14. [A recurrent case of psychotic withdrawal syndrome caused by monoamine oxidase inhibitors?].
    Sáez I; Jiménez F
    Med Clin (Barc); 1984 May; 82(19):864-5. PubMed ID: 6738220
    [No Abstract]   [Full Text] [Related]  

  • 15. Diethylpropion-induced psychosis reprecipitated by an MAO inhibitor: case report.
    Martin CA; Iwamoto ET
    J Clin Psychiatry; 1984 Mar; 45(3):130-1. PubMed ID: 6698946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenelzine Withdrawal-Associated Psychosis and Mania.
    Shao W; Brown T; Ayub S
    J Clin Psychopharmacol; 2017 Aug; 37(4):480-482. PubMed ID: 28609305
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychotic symptoms following buprenorphine withdrawal.
    Karila L; Berlin I; Benyamina A; Reynaud M
    Am J Psychiatry; 2008 Mar; 165(3):400-1. PubMed ID: 18316438
    [No Abstract]   [Full Text] [Related]  

  • 18. ["Addiction" to phenelzine - case report].
    Antosik-Wójcińska AZ; Bzinkowska D; Chojnacka M; Swiecicki Ł; Torbiński J
    Psychiatr Pol; 2013; 47(1):127-34. PubMed ID: 23888750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychosensorial manifestations observed in psychotic patients treated with betamimetic drugs].
    Feline A; Jouvent R
    Encephale; 1977; 3(2):149-58. PubMed ID: 19232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.